Moderna seeks approval for second booster shot in all adults
SilverV/iStock via Getty Images


Moderna (NASDAQ:MRNA) has asked the U.S. FDA to amend its Emergency Use Authorization for its COVID-19 vaccine to include a second booster dose for adults 18 years and older.
The request follows that of Pfizer (PFE) and BioNTech (BNTX) made on Tuesday. However, those companies are asking for the agency to expand a second booster in adults 65 years and older.

Moderna (MRNA) said its amendment is for a broader adult population to give the CDC and doctors flexibility in determining the appropriate use of an additional booster.
The company added its request is supported by recent data from Israel and the U.S. after the Omicron variant emerged.
Moderna (MRNA) is also working on an Omicron-specific vaccine and another that is a combination of its original vaccine with the Omicron one.